{"id":431880,"title":"What we heard: Draft guidance on expanded access clinical trials - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T06:50:51.703000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-draft-guidance-expanded-access-clinical-trials/what-we-heard.html","snippet":"What we heard: Draft guidance on expanded access clinical trials On this page Purpose Background Consultation approach Key themes Next steps Contact us Purpose The Draft guidance on expanded access clinical trials was published on August 2, 2024, and opened to the public for…","rawSnapshotUrl":"/api/snapshots/raw/431880","browseUrl":"https://replay.healtharchive.ca/job-6/20260102065051/https://www.canada.ca/en/health-canada/programs/consultation-draft-guidance-expanded-access-clinical-trials/what-we-heard.html#ha_snapshot=431880","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}